Novo Nordisk, Hims & Hers Health Shares React to Lawsuit

Pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) revealed today it is pursuing legal action against Hims & Hers Health Inc (NYSE:HIMS) for alleged patent infringement, after the telehealth giant introduced a weight-loss pill with the same active ingredient as its Wegovy drug -- priced at $149 -- at a much lower starting price of $49. Hims & Hers Health stopped offering the medication on Saturday, following threats of legal action from the U.S. Food and Drug Administration (FDA) and Novo Nordisk. The FDA als ...